Markelov, V.A.,
Korytina, G.F.,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N. Sh. (2024) of lnc
RNA (TP53TG1, LINC00342, H19, MALAT1, DNM3OS, and MEG3) and protein-coding (PTEN, TGFB2, FOXO3
Markelov, V.A.,
Korytina, G.F,
Aznabaeva, Y.G.,
Gibadullin, I.A.,
Akhmadishina, L.Z.,
Nasibullin, T.R.,
Kochetova, O.V.,
Avzaletdinov, A.M.,
Zagidullin, N Sh (2024) of lnc
RNA (TP53TG1, LINC00342, H19, MALAT1, DNM3OS, and MEG3) and protein-coding (PTEN, TGFB2, FOXO3
Enikeeva, Kadriia,
Rafikova, Guzel,
Sharifyanova, Yuliya,
Mulyukova, Diana,
Vanzin, Alexandr,
Pavlov, Valentin (2024) such as CpG island methylation, histone modification, and
microRNAs as biomarkers will improve the diagnosis
selective forces across
micro- and macroevolutionary timescales. Overall, this study demonstrates
, non-coding
RNA and epigenetic factors changes, which is a predisposing factor for MFDs development